NEMAURA MEDICAL INC (NMRD) Stock Analyst Ratings
NASDAQ:NMRD - Nasdaq - US6404422080 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to NMRD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 8.67. This target is 8133.62% above the current price.
NMRD was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about NMRD.
In the previous month the buy percentage consensus was at a similar level.
NMRD was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-08-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-07-17 | EF Hutton | Maintains | Buy -> Buy |
| 2023-03-30 | EF Hutton | Reiterate | Buy |
| 2023-02-28 | EF Hutton | Maintains | Buy |
| 2023-02-27 | HC Wainwright & Co. | Maintains | Buy |
| 2022-08-19 | HC Wainwright & Co. | Maintains | Buy |
| 2021-12-02 | EF Hutton | Initiate | Buy |